FR2021234B1 - - Google Patents

Info

Publication number
FR2021234B1
FR2021234B1 FR6936080A FR6936080A FR2021234B1 FR 2021234 B1 FR2021234 B1 FR 2021234B1 FR 6936080 A FR6936080 A FR 6936080A FR 6936080 A FR6936080 A FR 6936080A FR 2021234 B1 FR2021234 B1 FR 2021234B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR6936080A
Other languages
French (fr)
Other versions
FR2021234A1 (zh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Canada Inc
Original Assignee
Ayerst Mckenna and Harrison Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ayerst Mckenna and Harrison Inc filed Critical Ayerst Mckenna and Harrison Inc
Publication of FR2021234A1 publication Critical patent/FR2021234A1/fr
Application granted granted Critical
Publication of FR2021234B1 publication Critical patent/FR2021234B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
FR6936080A 1968-10-22 1969-10-21 Expired FR2021234B1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76975068A 1968-10-22 1968-10-22
US84553269A 1969-07-28 1969-07-28

Publications (2)

Publication Number Publication Date
FR2021234A1 FR2021234A1 (zh) 1970-07-17
FR2021234B1 true FR2021234B1 (zh) 1974-11-15

Family

ID=27118218

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6936080A Expired FR2021234B1 (zh) 1968-10-22 1969-10-21

Country Status (4)

Country Link
JP (1) JPS4843736B1 (zh)
DE (1) DE1953232A1 (zh)
FR (1) FR2021234B1 (zh)
GB (2) GB1292662A (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56171280U (zh) * 1980-05-21 1981-12-17
ATE489955T1 (de) * 2005-03-04 2010-12-15 Sucampo Ag Verfahren und zusammensetzung zur behandlung von peripheren gefässkrankheiten

Also Published As

Publication number Publication date
FR2021234A1 (zh) 1970-07-17
DE1953232A1 (de) 1970-04-30
GB1292661A (en) 1972-10-11
GB1292662A (en) 1972-10-11
JPS4843736B1 (zh) 1973-12-20

Similar Documents

Publication Publication Date Title
AU428130B2 (zh)
AU2374870A (zh)
AU5184069A (zh)
AU6168869A (zh)
AU6171569A (zh)
AU429879B2 (zh)
AU416157B2 (zh)
AU2581067A (zh)
AU4811568A (zh)
AU421558B1 (zh)
AU3789668A (zh)
AU4744468A (zh)
AU3224368A (zh)
AU2580267A (zh)
AU479393A (zh)
BE708888A (zh)
AU4503667A (zh)
AU4558658A (zh)
AU463027A (zh)
AU4270368A (zh)
BE727388A (zh)
AU479894A (zh)
AU4224469A (zh)
AU3083868A (zh)
AU2889368A (zh)

Legal Events

Date Code Title Description
ST Notification of lapse